Report of the Influenza Vaccination Program in Mexico (2006-2022) and Proposals for Its Improvement.

BACKGROUND: Influenza has continued to be an important public health challenge, and the WHO recommends that countries consider vaccination for persons at high risk. Mexico has such a program, and we sought to determine its current situation. MATERIAL AND METHODS: This study has an ecological, longitudinal, and retrospective design based on secondary information on the acquisition and application of vaccines against influenza from official data from 2006 to 2022. RESULTS: We found annual variability in the numbers of purchases and application of doses, with coverage of less than 90% of the total population every year; in addition, 17 million vaccines were not used in this period. DISCUSSION: This study shows the situation of the program at the national level. Two institutions acquired fewer the vaccines, while one purchased more for its target population, but the necessary vaccinations were not acquired. On average, 1.7 million of the vaccines purchased annually were not used, but in some years, more vaccines were applied than were purchased in all of the institutions. We also observed that, between institutions, the vaccine coverage was very different, from 21% to 180%. On average, 6.2 million people were not vaccinated annually, between 16% and 22% of the target population, demonstrating low coverage. When we compared the coverage data that we calculated to the data published by the institutions, a great difference was observed. CONCLUSIONS: We found inconsistencies in the data, indicating their unreliability and potential disorganization within the program, as the target populations of each institution were not clear. In addition, the application data may have had reporting errors. Adequate coverage was not achieved, and the coverage was different from that reported in the official sources. We propose the implementation of different systems for control, evaluation, and access to the information of the program.

Reverse transcription loop­mediated isothermal amplification has a high performance in the detection of SARS­CoV­2 in saliva samples and nasal swabs from asymptomatic and symptomatic individuals.

The detection of coronavirus disease 2019 cases represents a significant challenge at the epidemiological level. Limitations exist in effectively detecting asymptomatic cases, achieving good follow-up in hospitals without the infrastructure for reverse transcription-quantitative PCR (RT-qPCR) or in difficult-to-access areas and developing methods with the need for less invasive sampling procedures. Therefore, the present study evaluated the performance of the direct reverse transcription loop-mediated isothermal amplification (RT-LAMP) test for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the saliva and nasal samples of asymptomatic individuals belonging to the university population. In addition, this test was also assessed for effectiveness in symptomatic individuals referred from a hospital with poor infrastructure in molecular biology and located outside the urban area. The RT-LAMP assay was compared with the results obtained from the RT-qPCR nasopharyngeal swab test, where the diagnosis was confirmed by lateral flow immunoassay test for rapid antigen detection. A total of 128 samples were analyzed, of which 43% were symptomatic positive individuals, 25% were asymptomatic positive individuals and 32% were SARS-CoV2-negative control individuals. Among positive individuals, no differences were found between the Cq values determined by RT-qPCR. A sensitivity of 96.5% and a specificity of 97.6% was reported for the detection of SARS-CoV-2 in symptomatic individuals by salivary and nasal RT-LAMP, as well as a sensitivity of 100% and a specificity of 97.6% for the detection of SARS-CoV-2 in asymptomatic individuals. These findings indicated that performance of the direct RT-LAMP test using saliva and nasal samples has high sensitivity and specificity, which in turn suggest that it is a viable and reliable alternative for use in epidemiological monitoring.

Should asymptomatic bacteriuria be treated in lupus nephritis?

INTRODUCTION: The risk of infection in systemic lupus erythematosus (SLE) is associated with factors related to disease activity and immunosuppressive treatment. Recently, the persistence of asymptomatic bacteriuria (ASB) has been proposed as an environmental trigger for SLE and its flares, raising the question whether it should be treated systematically to reduce the risk of infection. To our knowledge, there is limited evidence on the screening and treatment of ASB in SLE. OBJECTIVE: The objective is to analyze the occurrence of infection and flare in patients with lupus nephritis with and without ASB. METHODS: A cross-sectional study of a cohort of patients with lupus nephritis during induction therapy with high-dose cyclophosphamide regimen was carried out between January 2018 and 2020, with a total of 37 patients investigated. Urine and blood samples from the two groups (with ASB and without ASB) where taken before the administration of cyclophosphamide. RESULTS: From the sampled 37 patients, 19 (51.4%) had ASB and 18 (48.6%) without ASB; both groups were well balanced in their demographics and clinical characteristics. No statistically significant association was found between the presence of ASB and the systemic lupus erythematosus disease activity index score (p = 0.604), and neither with the 24-h urine protein and leukocyte count (p > 0.177). Urinary tract infection occurred in 5.3% (1) of the patients with ASB, while 5.6% (1) of the patients in the group without ASB presented the infection, and the RR was 0.944 (0.06, 16.33) 95% CI; in addition, no statistically significant association was found between the presence of ASB and the occurrence of infection (p = 1,000). CONCLUSION: Our study did not find a statistically significant association of ASB with the occurrence of infection or disease activity. Further studies need it to clarify this, since treatment of ASB has been recognized as an important contributor to inappropriate antimicrobial use, which promotes emergence of antimicrobial resistance.

Effect of the Intake of a Traditional Mexican Beverage Fermented with Lactic Acid Bacteria on Academic Stress in Medical Students.

Dysbiosis of the gut microbiota has been associated with different illnesses and emotional disorders such as stress. Traditional fermented foods that are rich in probiotics suggest modulation of dysbiosis, which protects against stress-induced disorders. The academic stress was evaluated in medical students using the SISCO Inventory of Academic Stress before and after ingestion of an aguamiel-based beverage fermented with Lactobacillus plantarum, Lactobacillus paracasei and Lactobacillus brevis (n = 27) and a control group (n = 18). In addition, microbial phyla in feces were quantified by qPCR. The results showed that the consumption of 100 mL of a beverage fermented with lactic acid bacteria (3 × 108 cfu/mL) for 8 weeks significantly reduced academic stress (p = 0.001), while the control group (placebo intervention) had no significant changes in the perception of academic stress (p = 0.607). Significant change (p = 0.001) was shown in the scores for environmental demands, and physical and psychological factors. Consumption of the fermented beverage significantly increased the phyla Firmicutes and Bacteroidetes but not Gammaproteobacteria. No significant changes were found in the control group, except for a slight increase in the phylum Firmicutes. The intake of this fermented beverage suggest a modulation of gut microbiota and possible reduction in stress-related symptoms in university students, without changing their lifestyle or diet.

Cambios Dimensionales en Técnicas de Preservación Alveolar Bartee y Bio-Col con Xenoinjerto Inteross®

RESUMEN: La preservación de las dimensiones y contorno del reborde alveolar posterior a una extracción es de suma importancia para evitar problemas subsecuentes para la colocación de un implante dental. El objetivo de este estudio fue comparar los cambios dimensionales mediante el análisis en tomografía computarizada de haz cónico (CBCT) en sitios pre y post preservados con técnica Bartee y Bio-Col con xenoinjerto a los 6 meses de cicatrización. En un paciente de 62 años, se realizaron 6 preservaciones alveolares en órganos dentarios uniradiculares, con diagnóstico periodontal sin esperanza, grupo A la técnica de preservación alveolar Bartee (n= 3) y grupo B la técnica de preservación alveolar Bio-Col (n= 3). Se utilizó xenoinjerto (InterOss ® Anorganic Cancellous Bone Graft Granules 0,25- 1mm Sigma graft) en ambos grupos. En el grupo A se colocó injerto óseo en la totalidad del alveolo asistido por una membrana no reabsorbible de politetrafluoroetile no denso (Cytoplast ™ Regentex TXT-200 singles, Osteogenics Biomedical Inc, Lubbock, Texas). En el grupo B se colocó el injerto óseo en 3⁄4 del alveolo y el último 1⁄4 del alveolo fue ocupado por apósito de colágeno reabsorbible (CollaPlug ® Zimmer biomet). Se registraron mediciones obtenidas mediante CBCT inicial previa a la realización de preservaciones alveolares y se tomó una segunda CBCT a los 6 meses de cicatrización obteniendo la medición en sentido vertical y horizontal, coincidiendo en el plano de corte. Se observó mediante el análisis dimensional en grupo A y Grupo B obteniendo en sentido vertical un 13,58 % y 20,76 % de reabsorción y en sentido horizontal 13,45 % y 15,72 % respectivamente a los 6 meses de cicatrización, utilizando xenoinjerto por lo que no existe diferencia estadísticamente significativa en cuanto a los cambios dimensionales entre ambas técnicas p>0,05. La preservación alveolar proporciona una estabilidad dimensional contrarrestando el proceso de reabsorción fisiológica, siendo una opción predecible.

ABSTRACT: Preserving the dimensions and contour of the alveolar ridge after the dental extraction, it´s of utmost importance to avoidsubsequent problems for the placement of a dental implant. The objective of this study was compare the dimensional changes through the analysis in Cone-beam computed tomography (CBCT), in pre and post sites preserved with the Bartee and Bio-Col technique with xenograft at 6 months of healing. In a 62-year-old patient, 6 alveolar preservations were performed in uniradicular dental organs, with a hopeless periodontal diagnosis, group A the Bartee alveolar ridge preservation technique (n = 3) and group B the Bio-Col alveolar ridge preservation technique (n = 3). Xenograft (InterOss ® Anorganic Cancellous Bone Graft Granules 0.25-1mm Sigma graft) was used in both groups. In the group A a bone graft was placed in the entire socket, assisted by a dense non-absorbable polytetrafluoroethylene membrane (Cytoplast ™ Regentex TXT-200 singles, Osteogenics Biomedical Inc, Lubbock, Texas). In the group B the bone graft was placed in 3⁄4 of the socket and the last 1⁄4 of the socket was occupied by an absorbable collagen dressing (CollaPlug ® Zimmer biomet). Measurements obtained by initial CBCT before recording alveolar ridge preservations were recorded, and the second CBCT was taken 6 months after healing obtaining the measurement vertically and horizontally, coinciding in the section plane. It was observed through dimensional analysis in group A and Group B, obtaining 13.58% and 20.76% of reabsorption vertically and 13.45% and 15.72% respectively at 6 months of healing, using xenograft, so there is no statistical difference significant in terms of dimensional changes between both techniques p> 0.05. Alveolar ridge preservation provides dimensional stability by counteracting the physiological resorption process, being a predictable option.

[Management of ureteric colic with ketorolac and nifedipin vs. ketorolac and tamsulosin in the emergency room]. / Manejo del cólico ureteral con ketorolaco y nifedipina frente a ketorolaco y tamsulosina en el servicio de urgencias.

BACKGROUND: Ureteric colic is the most common symptom of lithiasis. It is caused by the presence of stones accumulated in the renal papillae. These stones often migrate down the ureter, causing a ureteric colic, characterized by a severe pain in the lumbar region. The aim of this study was to compare the use of ketorolac and nifedipine vs. ketorolac and tamsulosin for the medical treatment of pain caused by stones in the lower ureter. METHODS: Longitudinal study of 150 patients of 21-years or older with stones in the lower third of the ureter. 50% received ketorolac and nifedipine and the other 50%, ketorolac and tamsulosin. The Numeric Pain Rating Scale (NPRS) was used for the assessment of pain at admission and 4 and 12 hours after the treatment was administered. We used descriptive and inferential statistics (Mann-Whitney-Wilcoxon, chi-squared and Poisson regression). RESULTS: Mean age was 38.17 years; 54.7% were male and 45.3% female. NPRS mean was 9.69 (initially), 7.42 (at 4 hours) and 2.05 (at 12 hours). There were no significant differences in the initial measurement of pain between groups (p < 0.005); four and 12 hours later the pain decreased more in patients managed with ketorolac and nifedipine, p = 0.0041. There were no complications nor side effects in both treatments. CONCLUSION: The use of ketorolac and nifedipine is more effective than the use of ketorolac and tamsulosin for the management of pain caused by lower ureteral colic during the first 12 hours of treatment.

Introducción: el cólico renoureteral es la manifestación más común de la litiasis. Se trata de la presencia de cálculos en las papilas renales que frecuentemente migran hacia el uréter, ocasionando un cólico renoureteral, caracterizado por un dolor intenso en la región lumbar o en sus flancos. Se buscó comparar el uso del ketorolaco y nifedipino frente a ketorolaco y tamsulosina para el manejo del dolor ocasionado por litiasis en el tercio inferior del uréter. Métodos: estudio longitudinal en 150 pacientes mayores de 21 años con litiasis en tercio inferior del uréter. Al 50% se le administró ketorolaco y nifedipino y al otro 50% ketorolaco y tamsulosina. Se utilizó la escala numérica de dolor (END) al ingreso, a las 4 y a las 12 horas. La estadística fue descriptiva e inferencial (U de Mann-Whitney-Wilcoxon, chi cuadrada y regresión de Poisson). Resultados: la edad promedio fue 38.17 años y 54.7% de los pacientes fueron hombres. Inicialmente la END tuvo una media de 9.69, de 7.42 a las 4 horas y de 2.05 a las 12 horas. En la medición inicial del dolor no hubo diferencias significativas entre ambos grupos (p > 0.005); 4 y 12 horas después el dolor disminuyó más en los pacientes manejados con ketorolaco y nifedipino: p = 0.0041 y p = 0.000, respectivamente. No hubo complicaciones ni efectos secundarios en ambos tratamientos. Conclusión: la mancuerna ketorolaco y nifedipino es más efectiva que la del ketorolaco y la tamsulosina para el manejo del dolor del cólico renoureteral inferior durante las primeras 12 horas de tratamiento.